For women whose ovarian cancer has been in remission, restarting chemotherapy early on the basis of heightened serum CA125 concentration does not improve survival compared with postponing treatment until symptoms of relapse appear, according to a study published in the Oct. 2, cancer-themed issue of The Lancet.
FDA has issued warning letters to three companies that manufacture mouth-rinse products and market them with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.
FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.
FDA's Cardiovascular and Renal Drugs Advisory Committee voted 9 to 0 on Sept. 20 in favor of approving dabigatran etexilate (Pradaxa) for stroke prevention in patients with atrial fibrillation.
Abbott is complying with FDA's request to withdraw sibutramine (Meridia) from the U.S. market because the obesity drug may pose unnecessary cardiovascular risks to patients, FDA announced.
FDA has requested that all companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever, stop manufacturing this drug.
Amgen and Johnson & Johnson are recalling certain lots of the anemia drugs Epogen and Procrit because vials of the injectable medicines might develop tiny glass flakes that could cause blood clots and other serious health problems.
Bristol-Myers Squibb Co. recalled 60 million tablets of the blood pressure medication Avalide (irbesartan-hydrochlorothiazide) in the United States and Puerto Rico.
FDA has approved the oral multiple sclerosis treatment fingolimod 0.5 mg, as a first-line treatment for relapsing forms of multiple sclerosis. The approval makes fingolimod the first oral treatment indicated for relapsing forms of MS available in the United States.
Problems with the content and format of consumer medical information distributed with prescription drugs at retail pharmacies are the primary barriers to providing appropriate information to patients, a recent evaluation suggests. The reading level and length of CMI were also cited as shortcomings.
Partnering with Kaiser Foundation Health Plan of the Mid-Atlantic States, the American Pharmacists Association is offering coverage of medication therapy management services provided by pharmacists to employees who are members of Kaiser Permanente.
A new website sponsored by the National Community Pharmacists Association, www.PharmacyMatching.com, will bring together independent pharmacy owners preparing to sell their pharmacies, pharmacy owners who desire additional stores, and entrepreneurs seeking to become pharmacy owners.
Erectile dysfunction (ED) drugs purchased online may be worse than useless. They could pose significant health risks.
Costco Wholesale Corp.'s Ontario, Canada, region is testing interactive kiosks to educate pharmacy customers about medications and Costco health events.
Improper waste management affects both the environment and public health, so it is important to know the regulations governing pharmaceutical waste and to teach patients how best to dispose of unused drugs.
The anticipated approval of Gardasil for women 27 to 45 years of age has thrown the issue of vaccine reimbursement for pharmacists into the spotlight.
Pharmacists are uniquely situated to administer vaccines to their patients. But with so many problems still overlooked and unresolved, are community pharmacists ready for this new task?
Does she or doesn't she? Only her drugstore knows for sure. Even in today's racy culture, certain products are not discussed in polite company. Yet even blushworthy personal care products are essential, and their manufacturers are tuned to the preferences of 78 million style-conscious Baby Boomers.
Pharmacists speak out about quota systems, pain management, sexism in the work place, and pharmacy tobacco sales.
FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.
The need to find balance in her own life led Anna Garrett, PharmD, to establish the National Association for Women in Health Care, an organization committed to helping nurses, pharmacists, and other women healthcare professionals take care of themselves.
Want to save $1 million annually on pharmacy costs? Go lean, as in lean management. That's what Elkhart General Hospital did with medication administration.
Pharmacies soon may be stocking their shelves with laboratory-developed tests that first require FDA approval.
A survey of new Rx, new generic, and new OTC products
For this pharmacist, the best education is in magazine advertisements. The ads give the big three: What the drug does. Why it is better than the others on the market. What the dangers are.
Recalling the desperate fight for life that was waged by juvenile diabetes patients not even a century ago, "Breakthrough: The Dramatic Story of the Discovery of Insulin" will be on view at the New York Historical Society from October 2010 through January 2011.
Each year, community pharmacists are recognized by their peers through nominations for Drug Topics' annual Top Independent Pharmacists awards, which honor 3 pharmacists or pharmacy teams for their contributions to local life.
From medication therapy management to diabetes self-management education programs, retail pharmacists have begun to solidify a new role for themselves on the healthcare team.
Pfizer plans to acquire King Pharmaceuticals for $3.6 billion in cash, expanding its current portfolio of treatments for pain relief and pain management.
Abbott is complying with FDA's request to withdraw sibutramine (Meridia) from the U.S. market because the obesity drug may pose unnecessary cardiovascular (CV) risks to patients.
